top of page
Search


Microneedle Injection Molding for Real-Time Potassium Monitoring
Metyos , a Paris-based deeptech medical company, is developing a smart biowearable designed to transform how potassium levels are monitored in patients at risk of dyskalemia — a clinical term describing abnormal potassium levels in the blood. Dyskalemia encompasses both hyperkalemia (elevated serum potassium) and hypokalemia (reduced serum potassium), two clinically significant electrolyte disturbances frequently observed in patients with renal and cardiovascular conditions.
Lina
19 hours ago3 min read


Injection Molded Plastic Housing for 1 Channel EMG Sensor
The company specializes in robotic hand prostheses end-to-end development and production. Since 1998 Company continuously and patiently was developing robotic hand prostheses. Beginning with thin foil soft robot hand with 5DOF and ending with modern commercialized and daily-used worldwide product. This company is a true lives changing global innovator. Robotic hands are controlled by variety of sensors interacting with human body. We are proud that Micromolds was selected to

Scarlet Grey
Aug 16, 20223 min read


"Allergomedica" Uses Moulded Plastic Cases to Enable Health Tests Kits at Home
The Allergomedica (UAB Imunodiagnostika) clinic is an innovative place where not only comprehensive and professional help can be provided...

Dominic
Jul 25, 20222 min read


Uniweb Chooses Micromolds to Mould Grip Testing Device for Geriatrics
We used aluminium mico molds for the mold core and cavity and steel for the precision inserts.
Dominykas Turčinskas
Jul 21, 20222 min read


Injection Moulded Plastic Chips for Droplet Microfluidics
Droplet Genomics is a bio-tech company disrupting new ground in high performance analysis technologies.
Dominykas Turčinskas
Apr 25, 20222 min read


How Micromolds help Teltonika save time and costs when launching new products
Teltonika Telemedic almost two years ago initiated an innovative smart watch development project in the telemedicine industry.
Emilijus Šližauskas
Apr 21, 20224 min read
bottom of page

